Detalhe da pesquisa
1.
Human germinal center transcriptional programs are de-synchronized in B cell lymphoma.
Nat Immunol
; 19(9): 1013-1024, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30104629
2.
Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape.
Immunity
; 54(8): 1788-1806.e7, 2021 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34166622
3.
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.
Blood
; 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38557775
4.
B-cell non-Hodgkin lymphomas.
Lancet
; 403(10438): 1791-1807, 2024 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38614113
5.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34904799
6.
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities.
Blood
; 141(5): 467-480, 2023 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36322929
7.
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
Blood
; 141(10): 1209-1220, 2023 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36375119
8.
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Blood
; 142(26): 2327-2331, 2023 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37738563
9.
Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape.
Immunity
; 54(8): 1901, 2021 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34380065
10.
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile.
Br J Haematol
; 2024 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38735683
11.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34614146
12.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34936697
13.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood
; 140(11): 1229-1253, 2022 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35653592
14.
Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: real-world experience from a cancer center.
Haematologica
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38497151
15.
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study.
Haematologica
; 109(2): 553-566, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646664
16.
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Haematologica
; 109(4): 1149-1162, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646671
17.
Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes.
Haematologica
; 109(1): 200-208, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646672
18.
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.
Haematologica
; 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38450530
19.
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Am J Hematol
; 99(1): 48-56, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37853951
20.
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Br J Haematol
; 201(2): 256-266, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36740991